Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Company News

Management tracks: Flatiron picks Unum’s Vasconcelles to succeed Abernethy; plus Quell, Lytix and more

June 14, 2019 10:27 PM UTC

Flatiron Health Inc. hired Michael Vasconcelles as CMO. Vasconcelles, who was CMO of Unum Therapeutics Inc. (NASDAQ:UMRX), succeeds Amy Abernethy, who left to join FDA as principal deputy commissioner early this year. The Roche (SIX:ROG; OTCQX:RHHBY) unit provides curated real-world data to biopharma companies.

At Unum, Vasconcelles will be succeeded by Jessica Sachs, effective July 15. She was VP of clinical sciences at the T cell therapy company. Unum also hired Matthew Osborne as CFO and Mert Aktar as head of business and corporate development. Osborne was VP of corporate affairs, communications and investor relations at Voyager Therapeutics Inc. (NASDAQ:VYGR); Aktar was global head of hematology and immunology business development at Shire plc...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article